Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

BlackRock Health Sciences Opps Inv A (SHSAX)

38.76 Up 0.04(0.10%) May 24


Profile as of Feb 27, 2013Get Profile for:
BlackRock Health Sciences Opps Inv A
BLACKROCK MUNICIPAL BOND FUND, INC100 BELLEVUE PARKWAYWILMINGTON NJ 19809
Map
Phone: 800-441-7762
Fund Overview 
Category:Health
Fund Family:BlackRock
Net Assets:2.19B
Year-to-Date Return:9.74%
Yield:0.28%
Morningstar Rating:4 stars
Fund Inception Date:Dec 20, 1999
Morningstar Style Box 
Health
[View Category Definition]
View Top Health Funds
About the Morningstar Style Box
Management Information 
Thomas Callan
Lead Manager since Jan 30, 2005
Health Care-teamet hos BlackRock består af fire personer, hvoraf lederen Erin Xie har syv års erfaring med investering og otte års erfaring med forskning inden for biokemi og molekylær genetik. Erin Xie har været porteføljemanager siden 2003 og har været en del af teamet siden 2001. Teamet er placeret i Boston, Massachusetts.
Investment Information 
Min Initial Investment:1,000
Min Initial Investment, IRA:1,000
Min Initial Investment, AIP:50
Min Subsequent Investment:50
Min Subsequent Investment, IRA:50
Min Subsequent Investment, AIP:50
SHSAX can be purchased from 110 brokerages.

Fund Summary 
The investment seeks to provide long-term growth of capital. The fund invests at least 80% of total assets in equity securities, primarily common stock, of companies in health science and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It concentrates its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund is non-diversified.

Fund Operations 
Last Dividend (Dec 8, 2010) : 0.10
Last Cap Gain : 0.00
Annual Holdings Turnover (May 19, 2013) : 135.00%
Average for Category:47.95%
Fees & Expenses 
ExpenseSHSAXCategory Avg
Annual Report Expense Ratio (net):1.28%1.48%
Prospectus Net Expense Ratio:1.30%N/A
Prospectus Gross Expense Ratio:1.30%N/A
Max 12b1 Fee:0.25%N/A
Max Front End Sales Load:5.25%5.28%
Max Deferred Sales Load: N/A2.66%
3 Yr Expense Projection*:915646
5 Yr Expense Projection*:1,2001,001
10 Yr Expense Projection*:2,0101,973
* Per $10,000 invested